Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-20

Clinical Trial Update: The Effect of Zoledronate on the Prevention of Pneumonia in Hip Fracture Patients [Phase 4]

View source ↗

Summary

Phase 4 trial exploring whether zoledronate can prevent pneumonia in patients with hip fractures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zoledronate (zoledronic acid)

Snippet

Sponsor: The University of Hong Kong | Conditions: Hip Fractures, Pneumonia | Phase 4 | Status: UNKNOWN